Biotech News Alert: GenSpera (OTCQB:GNSZ) Announces Completion of Patient Enrollment in the Phase II Clinical Trial of Mipsagargin in Liver Cancer Patients

SAN ANTONIO - October 9, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that patient enrollment has been completed in the company's Phase II clinical trial in patients with liver cancer (hepatocellular carcinoma). Formal results of the study are expected to be available during the first quarter of 2015.

"We are grateful to the trial investigators for their efforts, as well as the patients and their loved ones who are supporting this important trial," said Craig Dionne, PhD, GenSpera's CEO. "The completion of the enrollment period for this trial marks another company milestone. The data we have collected to date establish proof of concept for mipsagargin's destruction of blood vessels within tumors and encouraging signs of potential anti-tumor activity. We anticipate similar results in our ongoing Phase II trials in patients with glioblastoma as well as our planned Phase II trial in patients with prostate cancer."

Breaking Tech News: NXT-ID Inc. (NASDAQ: NXTD) to Ring the Opening Bell of the NASDAQ Stock Market October 13^th

SHELTON, Conn. - October 9, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (NASDAQ: NXTD), a biometric authentication company focused on the growing mobile commerce market announces that in celebration of its recently completed financing and NASDAQ listing, it will ring the opening bell at the NASDAQ MarketSite in Times Square on Monday October 13^th.

Gino Pereira, CEO of NXT-ID, said, "This is a significant day for the company and our shareholders. The recently completed financing and listing on NASDAQ is a milestone in our development. He added," We look forward to bringing our biometric smart wallet, the Wocket™, to consumers later this year as the first of our biometric identification and verification products. In this age where data breaches are common place our ability to protect and secure the private information of consumers assumes increasing importance."

Breaking Tech News: NXT-ID (NASDAQ: NXTD) to Showcase Biometric Wocket Smart Wallet at 2015 CES (Consumer Electronics Show)

SHELTON, Conn. - October 6, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (NASDAQ: NXTD), a biometric authentication company focused on the growing mobile commerce market announces it will be exhibiting at the upcoming 2015 International CES (Consumer Electronics Show®), the world's gathering place for all who thrive on the business of consumer technologies, to be held in Las Vegas, January 6-9, 2015. The Company will be located at booths 21926 and 21927 in the South Hall lower level.

Gino Pereira, CEO of NXT-ID said, "With the recent news of extensive data theft at J.P. Morgan and Home Depot, consumers have no relief from the escalating concern over security breaches and identity theft from numerous data breaches before them."

Breaking Tech News: CNBC Commercial Airings for Wocket Smart Wallet (NASDAQ: NXTD) October 2^nd and 3^rd

SHELTON, Conn. - October 2, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (NASDAQ: NXTD and NXTDW), a biometric authentication company focused on the growing mobile commerce market, announces the airings for the national 30 second ads on Squawk Box, Fast Money and Mad Money.

The national ads resumed airing Monday September 29th running all week and will air October 2nd and October 3rd during market hours for interested investors and consumers.

The continuing ads that began airing on CNBC prior to the marketing launch in May at the Plaza Hotel are part of ongoing marketing initiatives introducing the unique features and benefits of the Wocket to consumers.